Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 11,970 shares at $30.97 ($372K) on 2018-07-16, disclosed to the SEC on 2018-07-18.
Open-market sale of $372k NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.97 | 5,284 | $164K | 44.0% |
| 2 | $30.97 | 5,284 | $164K | 44.0% |
| 3 | $31.93 | 1,402 | $45K | 12.0% |
| Total | $31.08 avg | 11,970 | $372K | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |